TD Cowen Has Lowered Expectations for MetLife (NYSE:MET) Stock Price

Key Points

• TD Cowen cut its target price on MetLife to $88 (from $91) while keeping a "buy" rating, which implies roughly a 25.9% upside from the current share price.
• Analyst consensus is a Moderate Buy with an average price target of $93.67, though recent broker moves are mixed—Weiss downgraded to Hold, Morgan Stanley trimmed its target, and UBS raised its target to $98.
• MetLife shares traded around $69.92, within a one‑year range of $65.21–$85.00, and the company recently beat Q4 EPS estimates ($2.49 vs. $2.34) with revenue up 27.6% year‑over‑year.

MetLife (NYSE:MET - Get Free Report) had its target price reduced by research analysts at TD Cowen from $91.00 to $88.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has a "buy" rating on the financial services provider's stock. TD Cowen's target price points to a potential upside of 25.86% from the company's current price.

Several other brokerages have also recently issued reports on MET. Weiss Ratings cut shares of MetLife from a "buy (b-)" rating to a "hold (c+)" rating in a report on Monday. Morgan Stanley lowered their price target on MetLife from $101.00 to $93.00 and set an "overweight" rating on the stock in a report on Tuesday, March 3rd. Barclays set a $90.00 price objective on MetLife in a report on Thursday, January 8th. Keefe, Bruyette & Woods lowered their target price on MetLife from $92.00 to $90.00 and set an "outperform" rating on the stock in a report on Tuesday, November 11th. Finally, UBS Group boosted their price target on MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a research note on Thursday, February 5th. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $93.67.

MetLife Stock Performance

Shares of MetLife stock traded down $0.68 during trading on Wednesday, hitting $69.92. 682,811 shares of the company's stock traded hands, compared to its average volume of 3,991,198. MetLife has a 1 year low of $65.21 and a 1 year high of $85.00. The business has a 50-day simple moving average of $76.83 and a 200-day simple moving average of $78.58. The stock has a market capitalization of $45.59 billion, a P/E ratio of 14.86, a PEG ratio of 0.65 and a beta of 0.76. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20.

MetLife (NYSE:MET - Get Free Report) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share for the quarter, topping analysts' consensus estimates of $2.34 by $0.15. The business had revenue of $52.44 billion during the quarter, compared to analyst estimates of $31.43 billion. MetLife had a return on equity of 21.81% and a net margin of 4.38%.MetLife's revenue was up 27.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.08 EPS. As a group, analysts forecast that MetLife will post 9.65 EPS for the current year.

Institutional Trading of MetLife

Several institutional investors and hedge funds have recently modified their holdings of MET. Blue Trust Inc. boosted its stake in shares of MetLife by 3.6% in the third quarter. Blue Trust Inc. now owns 3,585 shares of the financial services provider's stock worth $295,000 after acquiring an additional 125 shares during the period. Trustmark Bank Trust Department raised its stake in MetLife by 4.6% during the 3rd quarter. Trustmark Bank Trust Department now owns 2,870 shares of the financial services provider's stock valued at $236,000 after purchasing an additional 127 shares during the period. Daymark Wealth Partners LLC boosted its stake in MetLife by 4.2% in the 3rd quarter. Daymark Wealth Partners LLC now owns 3,192 shares of the financial services provider's stock worth $263,000 after purchasing an additional 130 shares during the period. Cornerstone Wealth Group LLC grew its holdings in MetLife by 4.9% during the 3rd quarter. Cornerstone Wealth Group LLC now owns 2,790 shares of the financial services provider's stock valued at $230,000 after buying an additional 130 shares in the last quarter. Finally, Commonwealth Retirement Investments LLC raised its position in shares of MetLife by 0.5% during the fourth quarter. Commonwealth Retirement Investments LLC now owns 26,953 shares of the financial services provider's stock valued at $2,128,000 after buying an additional 131 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.